Glaucoma in adults—screening, diagnosis, and management: a review

JD Stein, AP Khawaja, JS Weizer - Jama, 2021 - jamanetwork.com
Importance Glaucoma is the most common cause of irreversible blindness worldwide. Many
patients with glaucoma are asymptomatic early in the disease course. Primary care …

Artificial intelligence and deep learning in ophthalmology

DSW Ting, LR Pasquale, L Peng… - British Journal of …, 2019 - bjo.bmj.com
Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global
interest in recent years. DL has been widely adopted in image recognition, speech …

Primary open-angle glaucoma preferred practice pattern®

SJ Gedde, K Vinod, MM Wright, KW Muir, JT Lind… - Ophthalmology, 2021 - Elsevier
Background Primary open angle glaucoma (POAG) is a chronic, progressive ocular disease
causing loss of the optic nerve rim and retinal nerve fiber layer (RNFL) with associated …

Ocular benzalkonium chloride exposure: problems and solutions

MH Goldstein, FQ Silva, N Blender, T Tran, S Vantipalli - Eye, 2022 - nature.com
Preservatives in multidose formulations of topical ophthalmic medications are crucial for
maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK) …

The pathophysiology and treatment of glaucoma: a review

RN Weinreb, T Aung, FA Medeiros - Jama, 2014 - jamanetwork.com
Importance Glaucoma is a worldwide leading cause of irreversible vision loss. Because it
may be asymptomatic until a relatively late stage, diagnosis is frequently delayed. A general …

[PDF][PDF] Primary open-angle glaucoma preferred practice pattern® guidelines

BE Prum, LF Rosenberg, SJ Gedde, SL Mansberger… - …, 2016 - academia.edu
Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy in adults
in which there is a characteristic acquired atrophy of the optic nerve and loss of retinal …

Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up

SJ Gedde, WJ Feuer, KS Lim, K Barton, S Goyal… - Ophthalmology, 2020 - Elsevier
Purpose To report 3-year results of the Primary Tube Versus Trabeculectomy (PTVT) Study.
Design Unmasked multicenter randomized clinical trial. Participants Two hundred forty-two …

Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up

SJ Gedde, JC Schiffman, WJ Feuer… - American journal of …, 2012 - Elsevier
PURPOSE: To report 5-year treatment outcomes in the Tube Versus Trabeculectomy (TVT)
Study. DESIGN: Multicenter randomized clinical trial. METHODS: Settings: Seventeen …

Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up

SJ Gedde, LW Herndon, JD Brandt, DL Budenz… - American journal of …, 2012 - Elsevier
PURPOSE: To describe postoperative complications encountered in the Tube Versus
Trabeculectomy (TVT) Study during 5 years of follow-up. DESIGN: Multicenter randomized …

Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension

AP Tanna, M Johnson - Ophthalmology, 2018 - Elsevier
In an elegant example of bench-to-bedside research, a hypothesis that cells in the outflow
pathway actively regulate conventional outflow resistance was proposed in the 1990s and …